Cardiol Therapeutics (CRDL)
(Delayed Data from NSDQ)
$2.18 USD
+0.01 (0.46%)
Updated May 20, 2024 04:00 PM ET
After-Market: $2.18 0.00 (0.00%) 6:24 PM ET
2-Buy of 5 2
F Value F Growth A Momentum F VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
08/08/2024
Time: -- |
6/2024 | $-0.05 | 0.00% |
Earnings Summary
For their last quarter, Cardiol Therapeutics (CRDL) reported earnings of -$0.10 per share, missing the Zacks Consensus Estimate of -$0.06 per share. This reflects a negative earnings surprise of 66.67%. Look out for CRDL's next earnings release expected on August 08, 2024. For the next earning release, we expect the company to report earnings of -$0.05 per share, reflecting a year-over-year increase of 44.44%.
Earnings History
Price & Consensus
Zacks News for CRDL
Is it a Good Time to Invest in Aurinia Pharmaceuticals (AUPH)?
CRDL: What are Zacks experts saying now?
Zacks Private Portfolio Services